Diazepam alters cocaine self-administration, but not cocaine-stimulated locomotion or nucleus accumbens dopamine

Pharmacology Biochemistry and Behavior

Volumn 91, Issue 1, 2008, Pages 202-207

  Maier, Esther Y ^a   Ledesma, Ramon T ^a   Seiwell, Andrew P ^a   Duvauchelle, Christine L ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Addiction; Anxiety; Behavior; Drug abuse; In vivo microdialysis

Indexed keywords

COCAINE; DIAZEPAM; DOPAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR CHANGE; COCAINE DEPENDENCE; CONTROLLED STUDY; DRUG EFFECT; DRUG SELF ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; REINFORCEMENT;

ANALYSIS OF VARIANCE; ANIMALS; COCAINE; CONDITIONING, OPERANT; DIAZEPAM; DOPAMINE UPTAKE INHIBITORS; FOOD; HYPNOTICS AND SEDATIVES; MALE; MICRODIALYSIS; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; SELF ADMINISTRATION;

ANIMALIA; RATTUS;

EID: 50349095457     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2008.07.008     Document Type: Article

References (52)

1. Adinoff B. Neurobiologic processes in drug reward and addiction. Harv Rev Psychiatry 12 (2004) 305-320
2. Arnold J.M., and Roberts D.C. A critique of fixed and progressive ratio schedules used to examine the neural substrates of drug reinforcement. Pharmacol Biochem Behav 57 (1997) 441-447
3. Ben-Shahar O., Ahmed S.H., Koob G.F., and Ettenberg A. The transition from controlled to compulsive drug use is associated with a loss of sensitization. Brain Res 995 (2004) 46-54
4. Blanchard D.C., and Blanchard R.J. Cocaine potentiates defensive behaviors related to fear and anxiety. Neurosci Biobehav Rev 23 (1999) 981-991
5. Blanchard R.J., Hebert M.A., Dulloog L., Kaawaloa N., Nishimura O., and Blanchard D.C. Acute cocaine effects on stereotype and defense: an ethoexperimental approach. Neurosci Biobehav Rev 23 (1998) 179-188
6. Bystritsky A., Ackerman D.L., and Pasnau R.O. Low dose desipramine treatment of cocaine-related panic attacks. J Nerv Ment Dis 179 (1991) 755-758
7. Caine S.B., Heinrichs S.C., Coffin V.L., and Koob G.F. Effects of the dopamine D-1 antagonist SCH 23390 microinjected into the accumbens, amygdala or striatum on cocaine self-administration in the rat. Brain Res 692 (1995) 47-56
8. Carelli R.M. Nucleus accumbens cell firing and rapid dopamine signaling during goal-directed behaviors in rats. Neuropharmacology 47 Suppl 1 (2004) 180-189
9. Carrasco G.A., and Van de Kar L.D. Neuroendocrine pharmacology of stress. Eur J Pharmacol 463 (2003) 235-272
10. Charney D., Mihic S., and Harris R. Hypnotics and sedatives. In: Hardman J., Limbird L., and Gilman A. (Eds). Goodman & Gilman's the pharmacological basis of therapeutics (2001), McGraw-Hill, New York 399-427
11. Cox B.J., Norton G.R., Swinson R.P., and Endler N.S. Substance abuse and panic-related anxiety: a critical review. Behav Res Ther 28 (1990) 385-393
12. D'Souza M.S., and Duvauchelle C.L. Comparing nucleus accumbens and dorsal striatal dopamine responses to self-administered cocaine in naive rats. Neurosci Lett 408 (2006) 146-150
13. David V., Gold L.H., Koob G.F., and Cazala P. Anxiogenic-like effects limit rewarding effects of cocaine in balb/cbyj mice. Neuropsychopharmacology 24 (2001) 300-318
14. Delgado M.R., Olsson A., and Phelps E.A. Extending animal models of fear conditioning to humans. Biol Psychol 73 1 (2006) 39-48
15. DeVries A.C., and Pert A. Conditioned increases in anxiogenic-like behavior following exposure to contextual stimuli associated with cocaine are mediated by corticotropin-releasing factor. Psychopharmacology (Berl) 137 (1998) 333-340
16. Djeridane Y., Lemmer B., and Touitou Y. Diazepam affects both level and amplitude of rat locomotor activity rhythm but has no effect on core body temperature. Chronobiol Int 22 (2005) 975-985
17. Duvauchelle C.L., Ikegami A., and Castaneda E. Conditioned increases in behavioral activity and accumbens dopamine levels produced by intravenous cocaine. Behav Neurosci 114 (2000) 1156-1166
18. Emmett-Oglesby M.W., Peltier R.L., Depoortere R.Y., Pickering C.L., Hooper M.L., Gong Y.H., et al. Tolerance to self-administration of cocaine in rats: time course and dose-response determination using a multi-dose method. Drug Alcohol Depend 32 (1993) 247-256
19. Ettenberg A. Opponent process properties of self-administered cocaine. Neurosci Biobehav Rev 27 (2004) 721-728
20. Ettenberg A., and Geist T.D. Animal model for investigating the anxiogenic effects of self-administered cocaine. Psychopharmacology (Berl) 103 (1991) 455-461
21. Fernandes C., File S.E., and Berry D. Evidence against oppositional and pharmacokinetic mechanisms of tolerance to diazepam's sedative effects. Brain Res 734 (1996) 236-242
22. Geist T.D., and Ettenberg A. Concurrent positive and negative goalbox events produce runway behaviors comparable to those of cocaine-reinforced rats. Pharmacol Biochem Behav 57 (1997) 145-150
23. Geracioti Jr. T.D., and Post R.M. Onset of panic disorder associated with rare use of cocaine. Biol Psychiatry 29 (1991) 403-406
24. Giorgetti M., Javaid J.I., Davis J.M., Costa E., Guidotti A., Appel S.B., et al. Imidazenil, a positive allosteric GABAA receptor modulator, inhibits the effects of cocaine on locomotor activity and extracellular dopamine in the nucleus accumbens shell without tolerance liability. J Pharmacol Exp Ther 287 (1998) 58-66
25. Goeders N.E. A neuroendocrine role in cocaine reinforcement. Psychoneuroendocrinology 22 (1997) 237-259
26. Gunnarsdottir E.D., Pingitore R.A., Spring B.J., Konopka L.M., Crayton J.W., Milo T., et al. Individual differences among cocaine users. Addict Behav 25 (2000) 641-652
27. Hemby S.E., Martin T.J., Co C., Dworkin S.I., and Smith J.E. The effects of intravenous heroin administration on extracellular nucleus accumbens dopamine concentrations as determined by in vivo microdialysis. J Pharmacol Exp Ther 273 (1995) 591-598
28. Hoplight B.J., Vincow E.S., and Neumaier J.F. The effects of SB 224289 on anxiety and cocaine-related behaviors in a novel object task. Physiol Behav 84 (2005) 707-714
29. Hubner C.B., and Moreton J.E. Effects of selective D1 and D2 dopamine antagonists on cocaine self-administration in the rat. Psychopharmacology (Berl) 105 (1991) 151-156
30. Invernizzi R., Pozzi L., and Samanin R. Release of dopamine is reduced by diazepam more in the nucleus accumbens than in the caudate nucleus of conscious rats. Neuropharmacology 30 (1991) 575-578
31. Johnson D.N. Effect of diazepam on food consumption in rats. Psychopharmacology (Berl) 56 (1978) 111-112
32. Kelley A.E., and Berridge K.C. The neuroscience of natural rewards: relevance to addictive drugs. J Neurosci 22 (2002) 3306-3311
33. Kiyatkin E.A., and Bae D. Behavioral and brain temperature responses to salient environmental stimuli and intravenous cocaine in rats: effects of diazepam. Psychopharmacology (Berl) 196 3 (2007) 343-356
34. Kiyatkin E.A., Kiyatkin D.E., and Rebec G.V. Phasic inhibition of dopamine uptake in nucleus accumbens induced by intravenous cocaine in freely behaving rats. Neuroscience 98 (2000) 729-741
35. Liu Q.S., Pu L., and Poo M.M. Repeated cocaine exposure in vivo facilitates LTP induction in midbrain dopamine neurons. Nature 437 (2005) 1027-1031
36. Liu Y., Roberts D.C., and Morgan D. Effects of extended-access self-administration and deprivation on breakpoints maintained by cocaine in rats. Psychopharmacology (Berl) 179 (2005) 644-651
37. Mediratta P.K., Sharma K.K., and Rana J. Development of differential tolerance to the sedative and anti-stress effects of benzodiazepines. Indian J Physiol Pharmacol 45 (2001) 111-115
38. Moriyama M., Ichimaru Y., and Gomita Y. Behavioral suppression using intracranial reward and punishment: effects of benzodiazepines. Pharmacol Biochem Behav 21 (1984) 773-778
39. Olmstead M.C., Parkinson J.A., Miles F.J., Everitt B.J., and Dickinson A. Cocaine-seeking by rats: regulation, reinforcement and activation. Psychopharmacology (Berl) 152 (2000) 123-131
40. Paine T.A., Jackman S.L., and Olmstead M.C. Cocaine-induced anxiety: alleviation by diazepam, but not buspirone, dimenhydrinate or diphenhydramine. Behav Pharmacol 13 (2002) 511-523
41. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates. 4th edn (1998), Academic Press, San Diego
42. Pezze M.A., and Feldon J. Mesolimbic dopaminergic pathways in fear conditioning. Prog Neurobiol 74 (2004) 301-320
43. Phillips P.E., Stuber G.D., Heien M.L., Wightman R.M., and Carelli R.M. Subsecond dopamine release promotes cocaine seeking. Nature 422 (2003) 614-618
44. Pruessner J.C., Champagne F., Meaney M.J., and Dagher A. Dopamine release in response to a psychological stress in humans and its relationship to early life maternal care: a positron emission tomography study using [11C]raclopride. J Neurosci 24 (2004) 2825-2831
45. Smith D.E., and Landry M.J. Benzodiazepine dependency discontinuation: focus on the chemical dependency detoxification setting and benzodiazepine-polydrug abuse. J Psychiatr Res 24 Suppl 2 (1990) 145-156
46. Soderpalm B., Svensson L., Hulthe P., Johannessen K., and Engel J.A. Evidence for a role for dopamine in the diazepam locomotor stimulating effect. Psychopharmacology (Berl) 104 (1991) 97-102
47. Spivey W.H., and Euerle B. Neurologic complications of cocaine abuse. Ann Emerg Med 19 (1990) 1422-1428
48. Tarr J.E., and Macklin M. Cocaine. Pediatr Clin North Am 34 (1987) 319-331
49. Thiebot M.H., Jobert A., and Soubrie P. [Effects of muscimol and diazepam: a comparative study on behavioral inhibition induced by novelty, punishment, and nonreward (author's transl)]. Psychopharmacology (Berl) 61 (1979) 85-89
50. Walfish S., Massey R., and Krone A. Anxiety and anger among abusers of different substances. Drug Alcohol Depend 25 (1990) 253-256
51. Wesson D.R., and Smith D.E. Cocaine: treatment perspectives. NIDA Res Monogr 61 (1985) 193-203
52. Wolf B.C., Lavezzi W.A., Sullivan L.M., Middleberg R.A., and Flannagan L.M. Alprazolam-related deaths in Palm Beach County. Am J Forensic Med Pathol 26 (2005) 24-27